Disopyramide:SCnc:Pt:Ser/Plas:Qn

Known as: Disopyramide SerPl-sCnc, Disopyramide [Moles/volume] in Serum or Plasma, Disopyramide:Stof concentratie:Moment:Serum of plasma:Kwantitatief 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2005
0119832005

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The acute effects of i.v. disopyramide (1.5 mg/kg) on the hemodynamics of postischemic hearts were investigated in comparison to… (More)
Is this relevant?
2002
2002
Das Behandlungsziel bei Patienten mit rezidivierenden neurokardiogenen (= vasovagalen) Synkopen ist, das erneute Auftreten von… (More)
Is this relevant?
1993
1993
OBJECTIVE To examine the effects of saturable plasma binding on the pharmacokinetics of immediate-release (IR) and controlled… (More)
Is this relevant?
1985
1985
In order to choose the most appropriate antiarrhythmic agent, the basic haemodynamic characteristics of class I antiarrhythmic… (More)
Is this relevant?
1984
1984
The pharmacokinetics and bioavailability of total (bound plus unbound) and unbound disopyramide were compared following the… (More)
  • table II
  • table I
  • table IV
  • table V
  • table V
Is this relevant?
1983
1983
The influence of altered serum protein binding on the pharmacologic response to R- and S-disopyramide was studied in the rabbit… (More)
Is this relevant?